Summit Therapeutics to present at Oppenheimer Healthcare Conference on Feb 14

Summit Therapeutics Inc.

Presentation at Oppenheimer's 34th Annual Healthcare Life Sciences Conference on February 14, 2024 at 2:40PM ET.
Dr. Maky Zanganeh (CEO/President) and Robert W. Duggan (Chairman/CEO) will present on ivonescimab development.
Webcast available live and archived on Summit's website at www.smmttx.com.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.